MPO and posterior cortical atrophy: Compared with normal prostate cells (WPMY-1, PNT1A, RWPE1, RWPE2) and poorly metastatic PCa cells (C4-2, LNCaP), moderately metastatic PCa cells (DU145, PC3) presented lower levels of MPO expression (Figure 6C).